Naslov
Common clinical challenges when prescribing dermatologic therapy in geriatric patients.

Autori
Balić, A, Marinović, B, Čeović, R, Bukvić, Mokos Z.

Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, ostalo, stručni

Izvornik
Liječnički vjesnik / - , 2020, 54-54

Skup
Better Future of Healthy Ageing 2020

Mjesto i datum
Zagreb, Hrvatska, 03.06.2020. - 05.06.2020

Vrsta sudjelovanja
Poster

Vrsta recenzije
Međunarodna recenzija

Ključne riječi
geriatric patient, dermatologic therapy

Sažetak
One hundred years ago, only 2% of the U.S. population was over 65 years old. By 1980, this percentage was 11%, and by the year 2030, it will be 20%. With this tremendous increase in the proportion of elderly in the global population, geriatric medicine has become of great interest and importance. Data shows that around 40% of Americans between the ages of 65 and 74 years have had a skin disease significant enough to warrant treatment by a physician. Given the high incidence of significant dermatologic disorders in the elderly, it is clear that all health providers need to familiarize themselves with the diagnosis, prevention, and treatment of skin diseases seen in this population. The mainstay of therapeutic approach in the elderly should be proper skin care and treatment due to the preventable nature of most of the age-related skin diseases or treatable nature of another skin disease with their age- related specificities. Particular attention needs to be directed towards geriatric dermato- pharmacology as an ageing population has brought many therapeutic challenges that we need to recognize and overcome. Safely prescribing in the field of geriatric dermatology is a complicated task since there is an increased risk of drug interactions that may be caused by various factors including the prescribing factor, patient-related factors or difficulties within the health-care system such as poor or insufficient communication between the patients and medical professionals. Dermatologists and other specialists should be aware that prescribing medicines to their mature patients is a dynamic process that involves many patient-doctor-health-care providers’ oriented steps, which may influence the therapeutic result. Also, they need to be aware of the age-related changes in the pharmacokinetics of common dermatologic drugs, their various interactions potentially occurring in the elderly, and the principles, and evidence-based strategies for their prevention, detection and management to improve adherence to therapy in order to ensure the best and the safest treatment of dermatoses occurring in the seniors. By implementing these gerontopharmacologic principles and strategies, and a team-based, holistic, personalized, and multi-disciplinary professional dynamic approach we can achieve the desired therapeutic outcome and improved quality of life for this fragile group of patients.

Izvorni jezik
Engleski

POVEZANOST RADA